Florida Board of Pharmacy Proposes Compounding Rule Amendment
Comments Open Until September 8, 2017
The
Florida Board of Pharmacy
has proposed a rule amendment to the definition of compounding to clarify that the compounding of human products (sterile and nonsterile) for office use must be in compliance with 21 USC 353b, including being registered as an outsourcing facility.
Please note - Comments are due by September 8, 2017.
Comments can be directed to:
C. Erica White, Executive Director, Board of Pharmacy, 4052 Bald Cypress Way, Bin C04, Tallahassee, Florida 32399-3254
Florida
Definition of Compounding
Citation: 64B16-27.700
Comments/Briefs Due: 9/8/2017
Published
Summary: The Board of Pharmacy has proposed the rule amendment so that the rule does not conflict with state or federal law and to make clear that office use compounding of products intended for human use (sterile and nonsterile) shall require being registered as an Outsourcing Facility as defined by ยง465.003(19), Fla. Stat. (2016).
History: Comment deadline: 09/08/17
Notice of Proposed Rule published on 08/18/17
Notice of Development of Rulemaking published on 07/21/17
IACP's
Compounders Stateside is a members-only one-stop resource for
state tracking, including legislative and regulatory updates, as well as state Boards of Pharmacy updates. Provided exclusively for IACP Members, Compounders Stateside updates can be
found here.
